ArticleCell death & disease2021

BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair.

Shaolu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.